Erin B. Dickerson

3.7k total citations · 1 hit paper
52 papers, 2.8k citations indexed

About

Erin B. Dickerson is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Erin B. Dickerson has authored 52 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 21 papers in Oncology and 20 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Erin B. Dickerson's work include Veterinary Oncology Research (14 papers), Virus-based gene therapy research (11 papers) and Vascular Tumors and Angiosarcomas (8 papers). Erin B. Dickerson is often cited by papers focused on Veterinary Oncology Research (14 papers), Virus-based gene therapy research (11 papers) and Vascular Tumors and Angiosarcomas (8 papers). Erin B. Dickerson collaborates with scholars based in United States, France and Panama. Erin B. Dickerson's co-authors include John F. McDonald, Hunghao Chu, Erik C. Dreaden, Ivan H. El‐Sayed, Xiaohua Huang, Mostafa A. El‐Sayed, Nasim Akhtar, Robert Auerbach, Stuart C. Helfand and Jaime F. Modiano and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and Cancer Research.

In The Last Decade

Erin B. Dickerson

52 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice

2008 948 citations Erin B. Dickerson, Erik C. Dreaden et al. Cancer Letters profile →

Peers

Countries citing papers authored by Erin B. Dickerson

Since Specialization

Citations

This map shows the geographic impact of Erin B. Dickerson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erin B. Dickerson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erin B. Dickerson more than expected).

Fields of papers citing papers by Erin B. Dickerson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erin B. Dickerson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erin B. Dickerson. The network helps show where Erin B. Dickerson may publish in the future.

Co-authorship network of co-authors of Erin B. Dickerson

This figure shows the co-authorship network connecting the top 25 collaborators of Erin B. Dickerson. A scholar is included among the top collaborators of Erin B. Dickerson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erin B. Dickerson. Erin B. Dickerson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PIK3CA mutation fortifies molecular determinants for immune signaling in vascular cancers 2024 ·Cancer Gene Therapy ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Hai Dang Nguyen, Erin B. Dickerson, Jong Hyuk Kim	1
2	FGFR2 mutations promote endometrial cancer progression through dual engagement of EGFR and Notch signalling pathways 2023 ·Clinical and Translational Medicine ·(unknown), Jesús González Bosquet, (unknown), Eric J. Devor, Erin B. Dickerson, Warren B. Nothnick, Priya D. Issuree, Kimberly K. Leslie, Thorsten Maretzky	14
3	Propranolol Sensitizes Vascular Sarcoma Cells to Doxorubicin by Altering Lysosomal Drug Sequestration and Drug Efflux 2021 ·Frontiers in Oncology ·(unknown), Jong Hyuk Kim, Clarissa Amaya, (unknown), Ali Khammanivong, (unknown), David R. Brown, Josephine Taylor, Brad A. Bryan, Erin B. Dickerson	26
4	The beta adrenergic receptor antagonist propranolol alters mitogenic and apoptotic signaling in late stage breast cancer 2019 ·Biomedical Journal ·(unknown), Armando Varela‐Ramírez, Erin B. Dickerson, Eddy Pasquier, Alireza Torabi, Renato J. Aguilera, Zeina Nahleh, Brad A. Bryan	57
5	Transcriptome profiling in oral cavity and esophagus tissues from (S)‐N′‐nitrosonornicotine‐treated rats reveals candidate genes involved in human oral cavity and esophageal carcinogenesis 2016 ·Molecular Carcinogenesis ·Ali Khammanivong, Arunkumar Anandharaj, Xuemin Qian, Jung Min Song, Pramod Upadhyaya, Silvia Balbo, Dipankar Bandyopadhyay, Erin B. Dickerson, Stephen S. Hecht, Fekadu Kassie	10
6	RNA-sequencing studies identify genes differentially regulated during inflammation-driven lung tumorigenesis and targeted by chemopreventive agents 2015 ·Inflammation Research ·Xuemin Qian, Ali Khammanivong, Jung Min Song, (unknown), Pramod Upadhyaya, Erin B. Dickerson, Fekadu Kassie	9
7	SMURF1 silencing diminishes a CD44-high cancer stem cell-like population in head and neck squamous cell carcinoma 2014 ·Molecular Cancer ·Ali Khammanivong, Raj K. Gopal, Erin B. Dickerson	32
8	Frequent and increased expression of human METCAM/MUC18 in cancer tissues and metastatic lesions is associated with the clinical progression of human ovarian carcinoma 2014 ·Taiwanese Journal of Obstetrics and Gynecology ·(unknown), Erin B. Dickerson	19
9	Lysosomal drug sequestration as a mechanism of drug resistance in vascular sarcoma cells marked by high CSF-1R expression 2014 ·PubMed ·(unknown), (unknown), Ali Khammanivong, Gary K. Schwartz, Erin B. Dickerson	16
10	Hemangiosarcoma and its cancer stem cell subpopulation are effectively killed by a toxin targeted through epidermal growth factor and urokinase receptors 2013 ·International Journal of Cancer ·(unknown), Aric M. Frantz, (unknown), Erin B. Dickerson, Daniel A. Vallera, Jaime F. Modiano	30
11	Imatinib and Dasatinib Inhibit Hemangiosarcoma and Implicate PDGFR-β and Src in Tumor Growth 2013 ·Translational Oncology ·Erin B. Dickerson, (unknown), Wade Edris, Jeffrey Tyner, (unknown), (unknown), Marc Loriaux, Brian Druker, Stuart C. Helfand	24
12	Chemosensitization of cancer cells by siRNA using targeted nanogel delivery 2010 ·BMC Cancer ·Erin B. Dickerson, William Blackburn, Michael H. Smith, (unknown), L. Andrew Lyon, John F. McDonald	106
13	Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice breakdown → 2008 ·Cancer Letters ·Erin B. Dickerson, Erik C. Dreaden, Xiaohua Huang, Ivan H. El‐Sayed, Hunghao Chu, (unknown), John F. McDonald, Mostafa A. El‐Sayed	948
14	Evidence that p53-Mediated Cell-Cycle-Arrest Inhibits Chemotherapeutic Treatment of Ovarian Carcinomas 2007 ·PLoS ONE ·Carlos S. Moreno, Lilya V. Matyunina, Erin B. Dickerson, (unknown), Nathan J. Bowen, Sanjay Logani, Benedict B. Benigno, John F. McDonald	49
15	Emerging roles for PAX8 in ovarian cancer and endosalpingeal development 2006 ·Gynecologic Oncology ·Nathan J. Bowen, Sanjay Logani, Erin B. Dickerson, (unknown), (unknown), Benedict B. Benigno, John F. McDonald	160
16	Biological and molecular characterization of a canine hemangiosarcoma-derived cell line 2005 ·Research in Veterinary Science ·Douglas H. Thamm, Erin B. Dickerson, Nasim Akhtar, Rachel L. Lewis, Robert Auerbach, Stuart C. Helfand, E. Gregory MacEwen	40
17	Interleukin-12 Inhibits Tumor Growth in a Novel Angiogenesis Canine Hemangiosarcoma Xenograft Model 2004 ·Neoplasia ·Nasim Akhtar, Marcia L. Padilla, Erin B. Dickerson, Howard Steinberg, Matthew Breen, Robert Auerbach, Stuart C. Helfand	58
18	Canine malignant hemangiosarcoma as a model of primitive angiogenic endothelium 2004 ·Laboratory Investigation ·Susan Fosmire, Erin B. Dickerson, A. Scott, (unknown), (unknown), (unknown), Marcia L. Padilla, Ashley Frazer‐Abel, Nasim Akhtar, David M. Getzy, John Wojcieszyn, Matthew Breen, Stuart C. Helfand, Jaime F. Modiano	84
19	Potential to Target Dysregulated Interleukin-2 Receptor Expression in Canine Lymphoid and Hematopoietic Malignancies as a Model for Human Cancer 2002 ·Journal of Immunotherapy ·Erin B. Dickerson, Susan Fosmire, Marcia L. Padilla, Jaime F. Modiano, Stuart C. Helfand	21
20	The sponge/Matrigel angiogenesis assay 2002 ·Angiogenesis ·Nasim Akhtar, Erin B. Dickerson, Robert Auerbach	120

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact